The mechanism of apoptosis in human platelets during storage

Transfusion

Volumn 40, Issue 11, 2000, Pages 1320-1329

  Li, Junzhi ^a   Xia, Yuping ^a   Bertino, Amy M ^a   Coburn, John P ^a   Kuter, David J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CASPASE 3; GELSOLIN; LIPOCORTIN 5; PHOSPHATIDYLSERINE; PROTEIN BCL 2; RIBONUCLEASE; TETRAZOLIUM;

APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SUBSTRATE; ENZYME SUBUNIT; HUMAN; HUMAN CELL; PROTEIN DEGRADATION; THROMBOCYTE ACTIVATION; THROMBOCYTE PRESERVATION;

APOPTOSIS; BLOOD PLATELETS; BLOOD PRESERVATION; BLOOD PROTEINS; CASPASE 3; CASPASES; CELL SURVIVAL; ENZYME ACTIVATION; GELSOLIN; HUMANS;

EID: 0033725182     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2000.40111320.x     Document Type: Article

References (35)

1. Cell death in development
2. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis
3. Caspases: Intracellular signaling by proteolysis
4. ERICE, a novel FLICE-activatable caspase
5. Murine caspase-11, an ICE-interacting protease, is essential for the activation of ICE
6. Caspase-14 is a novel developmentally regulated protease
7. Caspase-3-generated fragment of gelsolin: Effector of morphological change in apoptosis
8. Requirement for RNA and protein synthesis or induced regression of the tadpole tail in organ culture
9. Are caspases involved in the death of cells with a transcriptionally inactive nucleus? Sperm and chicken erythrocytes
10. Programmed cell death and Bcl-2 protection in the absence of a nucleus
11. Platelet kinetics
12. Platelet membrane integrity during storage and activation
13. Cytokines in platelet concentrates: A comparison of apheresis platelet (haemonetics) and filtered and unfiltered pooled buffy-coat derived platelet concentrates
14. Thrombopoietin and the TPO receptor during platelet storage
15. Development of optimal techniques for cryopreservation of human platelets. I. Platelet activation during cold storage (at 22 and 8 degrees C) and cryopreservation
16. Platelet membrane early activation markers during prolonged storage
17. Calpain functions in a caspase-independent manner to promote apoptosis-like events during platelet activation
18. Role of caspase in a subset of human platelet activation responses
19. Chronic neutropenia mediated by fas ligand
20. Restoration of in vitro responses in platelets stored in plasma
21. Platelet activation may explain the storage lesion in platelet concentrates
22. Inhibition of cytokine accumulation and bacterial growth during storage of platelet concentrates at 4°C with retention of in vitro functional activity
23. Effect of filtration of platelet concentrates on the accumulation of cytokines and platelet release factors during storage
24. Cytokine levels in platelet concentrates: Quantitation by bioassays and immunoassays
25. Cytokine generation in stored platelet concentrates
26. Transforming growth factor beta is increased in plasma of patients with hematologic malignancies after transfusion of platelet concentrates
27. Generation of interleukin 8 in stored apheresis platelet concentrates and the preventive effect of prestorage ultraviolet Bradiation
28. Activation of caspase 3 (CPP32)-like proteases is essential for TNF-alpha-induced hepatic parenchymal cell apoptosis and neutrophil-mediated necrosis in a murine endotoxin shock model
29. Apoptosis of colorectal adenocarcinoma (COLO 201) by tumour necrosis factor-alpha (TNF-alpha) and/or interferon-gamma (IFN-gamma), resulting from down-modulation of Bcl-2 expression
30. A cloning method for caspase substrates that uses the yeast two-hybrid system: Cloning of the antiapoptotic gene gelsolin
31. Regulation of fas-ligand expression during activation-induced cell death in T lymphocytes via nuclear factor kappaB
32. Mitogen-activated protein kinase kinase kinase 1 activates androgen receptor-dependent transcription and apoptosis in prostate cancer
33. Mechanisms of p53-mediated apoptosis
34. P-selectin and platelet clearance
35. FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis